oncology

Sumitomo merges U.S. biotechs to create oncology division
Sumitomo merges U.S. biotechs to create oncology division
Fierce Biotech
Sumitomo Dainippon
Tolero Pharmaceuticals
Boston Biomedical
oncology
M&A
Flag link:
Athenex features real patients in first oncology campaign as it readies key breast cancer filing
Athenex features real patients in first oncology campaign as it readies key breast cancer filing
Fierce Pharma
oncology
Athenex
metastatic breast cancer
patients
Flag link:
GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Ideaya
GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Ideaya
Fierce Biotech
GSK
cancer
R&D
oncology
Ideaya
genome editing
Flag link:
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track
Xconomy
GSK
oncology
Zejula
niraparib
belantamab mafodotin
dostarlimab
immuno-oncology
Flag link:
Eight Fraudulent Cancer Research Studies Contained The Same Copied Results. How Does This Happen?
Eight Fraudulent Cancer Research Studies Contained The Same Copied Results. How Does This Happen?
Forbes
cancer
oncology
academic research
research fraud
Flag link:
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline
Xconomy
Cullinan Oncology
cancer
oncology
Flag link:
ASCO 2020 virtual annual meeting – day 1 (live updates)
ASCO 2020 virtual annual meeting – day 1 (live updates)
Pharmaforum
ASCO 2020
virtual meetings
oncology
cancer
COVID-19
pandemic
Flag link:
J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic
J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic
Fierce Pharma
cancer
JNJ
AbbVie
Roche
pharma advertising
oncology
Flag link:
With money flowing, Pliant Therapeutics heads to public well
With money flowing, Pliant Therapeutics heads to public well
Endpoints
IPOs
Pliant Therapeutics
Rare Diseases
oncology
Flag link:
Blood test for cancer detection company Grail rakes in $390M in latest round
Blood test for cancer detection company Grail rakes in $390M in latest round
Endpoints
diagnostics
Grail
oncology
cancer
Flag link:
Go or no go? Oncology dominates upcoming decisions
Go or no go? Oncology dominates upcoming decisions
EP Vantage
FDA
oncology
AstraZeneca
Lynparza
ovarian cancer
prostate cancer
Bristol-Myers Squibb
Opdivo
lung cancer
Flag link:
Will Last Week's Biotech IPO Outperform in a Recession?
Will Last Week's Biotech IPO Outperform in a Recession?
Motley Fool
IPOs
ORIC Pharmaceuticals
cancer
oncology
Flag link:
LegoChem Biosciences, Iksuda collaborate to develop antibody-drug conjugates
LegoChem Biosciences, Iksuda collaborate to develop antibody-drug conjugates
Pharmaceutical Business Review
LegoChem Biosciences
South Korea
oncology
antibody-drug conjugate
Iksuda
Flag link:
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer
Xconomy
PIC Therapeutics
Harvard
cancer
oncology
Flag link:
Zentalis Pharmaceuticals Raises $165 Million in Expanded IPO
Zentalis Pharmaceuticals Raises $165 Million in Expanded IPO
Bloomberg
Zentalis
cancer
oncology
IPOs
Flag link:
AI and cancer care: 3 ways artificial intelligence may transform cancer outcomes
AI and cancer care: 3 ways artificial intelligence may transform cancer outcomes
Pharmaforum
artificial intelligence
machine learning
cancer
oncology
imaging
liquid biopsies
Flag link:
Grail's Next-Gen Multi-Cancer Test Detects 50 Early-Stage Cancers with 93% Accuracy
Grail's Next-Gen Multi-Cancer Test Detects 50 Early-Stage Cancers with 93% Accuracy
BioSpace
Grail
diagnostics
oncology
cancer
Flag link:
Former Shire execs set up shop to take a shot at 'under the radar' cancer target
Former Shire execs set up shop to take a shot at 'under the radar' cancer target
Endpoints
cancer
oncology
Shire
OncoOne
Flag link:
New Meds Set to Reshape US CNS and oncology Markets
New Meds Set to Reshape US CNS and oncology Markets
Xconomy
CNS
oncology
cancer
Clarivate Analytics
Biohaven
rimegepant
Novartis
OMB-157
Flag link:
AstraZeneca cans cancer pipeline efforts
AstraZeneca cans cancer pipeline efforts
Fierce Biotech
AstraZeneca
earnings
R&D
cancer
oncology
Flag link:

Pages